Adaptive Trial Designs: BIO, Janssen, ACRO Call for Tweaks to FDA Draft Guidance

Clinical research organizations along with pharmaceutical and biotechnology companies called for certain clarifications and terminology harmonization in the US Food and Drug Administration’s (FDA) recently released draft guidance on adaptive clinical trial designs.